Back HIV Prevention

September 27 Is National Gay Men's HIV/AIDS Awareness Day

Tuesday, September 27, is National Gay Men's HIV/AIDS Awareness Day (NGMHAAD), a day of action to call attention to the disproportionate effect of the epidemic on gay, bisexual, and other men who have sex with men.

alt

Read more:

AIDS 2016: How Can Clinical Services Engage Men Who Have Sex With Men in Africa?

Men who have sex with men (MSM) living in African countries have an extremely high burden of HIV, Stefan Baral of Johns Hopkins University reminded delegates at the recent 21st International AIDS Conference (AIDS 2016) in Durban. But in situations often marked by widespread social disapproval of homosexual behavior, health services for MSM are few and far between.

alt

Read more:

AIDS 2016: Neglect of Infectious Disease in Prisons Highlighted at Conference

A special issue of The Lancet was published to coincide with the recent 21st International AIDS Conference in Durban, containing a comprehensive seriesof reviews on the burden of HIV, hepatitis B, hepatitis C, and tuberculosis (TB) among prisoners worldwide.

alt

Read more:

AIDS 2016: NYC Clinic Outlines How to Improve PrEP Uptake by Transgender People

Dedicated efforts are needed to engage transgender men and women with clinical services and to encourage them to use pre-exposure prophylaxis (PrEP), Asa Radix from the Callen-Lorde Community Health Center in New York said during a presentation at the recent 21st International AIDS Conference (AIDS 2016) in Durban.

alt

Read more:

AIDS 2016: PrEP Study Achieves High Engagement and Adherence Among Black Gay Men

What was described at the 21st International AIDS Conference (AIDS 2016) as the first PrEP trial devised and run by black gay men has shown that high levels of pre-exposure prophylaxis (PrEP) use, retention, and adherence can be achieved in a demonstration project if recruitment and support structures are tailored to the needs of black men who have sex with men.

alt

Read more:

Donors Pledge $13 Billion to Replenish Global Fund

International donors committed to provide $12.9 billion over 3 years for the Global Fund to Fight AIDS, TB and Malaria at the fund's fifth replenishment conference, held last week in Montreal. "This replenishment is an enormous contribution to our collective ambition of ending AIDS," said UNAIDS executive director Michel Sidibé.

alt

Read more:

FDA Taking Public Comment on Potential Changes to Gay Blood Donation Policy

Through late November the U.S. Food and Drug Administration (FDA) is currently accepting public comments, supported by scientific evidence, as it considers changes to its policy restricting blood donations by gay and bisexual men. Instead of the current 1-year waiting period after a man has sex with another man, the agency is considering a more individualized policy that focuses on risk behavior rather than sexual orientation or self-identification.

alt

Read more:

Sweden Becomes First Country to Achieve UNAIDS 90-90-90 Targets

Sweden has become the first country to achieve the UNAIDS/World Health Organization (WHO) 90-90-90 targets, research published in the August 18 advance edition of HIV Medicine shows. At the end of 2015, 90% of HIV cases in Sweden were diagnosed, 99.8% of people were linked to care, and 95% of people taking antiretroviral therapy for at least 6 months had a viral load below 50 copies/mL.

alt

Read more:

AIDS 2016: Earlier HIV Treatment Is Not Over-burdening Health Services

Earlier antiretroviral treatment initiation is not overwhelming rural health services in South Africa, but changes in treatment eligibility criteria alone may not be enough to increase the number of people on treatment substantially, and more investment will be needed in testing and linkage to care to reach treatment coverage goals, research presented at the recent 21st International AIDS Conference (AIDS 2016) shows.

alt

Read more:

USCA 2016: U.S. Conference on AIDS Discusses HIV Prevention and Access to Care

The U.S. Conference on AIDS (USCA 201c), sponsored by the National Minority AIDS Council,is taking place this week, September 15-18, in Hollywood, Florida. The largest U.S. conference focused on the community-based response to HIV/AIDS, USCA brings together researchers, front-line providers, community organizations, government policymakers, and people living with HIV and their advocates to discuss how to improve access to HIV prevention, care, and treatment.

alt

Read more:

San Francisco Annual Report Shows New Low in HIV Infections But Disparities Remain

On September 1, the San Francisco Department of Public Health released its HIV Epidemiology Annual Report 2015, showing that the number of newly diagnosed HIV infections has continued to fall and people with HIV are being linked to care and achieving viral suppression more quickly. But some notable disparities remain, with African-American men and women not benefitting as much as the population as a whole.

alt

Read more:

September 18 is National HIV/AIDS and Aging Awareness Day

Sunday, September 18, is the annual observance of National HIV/AIDS and Aging Awareness Day (NHAAAD), an opportunity to focus on the HIV prevention, testing, care, and treatment for the aging population, as well as the health and well-being of the growing population of older people living with HIV.

alt

Read more:

AIDS 2016: Managing Non-Communicable Diseases Among People Living with HIV

Speakers at the recent 21st International AIDS Conference in Durban addressed non-communicable diseases (NCDs) -- including cardiovascular diseases, diabetes, cancers, and other illnesses -- which have become more common complications for people with HIV who are living longer on antiretroviral therapy (ART). NCDs represent a significant challenge in low- and middle-income countries, where the burden of these illnesses has been reaching epidemic proportions, but where health systems have traditionally focused on providing episodic rather than chronic care.

alt

Read more:

Nationwide PrEP Search Engine Debuts at U.S. Conference on AIDS

Emory University and partners have developed a new web-based directory of PrEP providers across the U.S., launching the project at the U.S. Conference on AIDS taking place this week in Hollywood, Florida. The search engine can be used to help people find physicians or clinics in their area that will prescribe Truvada (tenofovir/emtricitabine) for HIV prevention.

alt

Read more:

AIDS 2016: San Francisco Sees Progress in Getting to Zero Initiative

San Francisco continues to make good progress with its "Getting to Zero" initiative, which aims to achieve the triple goal of zero new HIV infections, zero AIDS deaths, and zero stigma for people living with HIV. But not all groups are doing equally well, according to a presentation at the recent 21st International AIDS Conference (AIDS 2016) in Durban.

alt

Read more:

AIDS 2016: Vaginal Ring for HIV Prevention is Effective and Acceptable

An updated adherence analysis from the ASPIRE study indicates that consistent users of a vaginal ring containing dapivirine experienced 65% fewer HIV infections, according to a presentation at the recent 21st International AIDS Conference (AIDS 2016) in Durban. Moreover, African women who took part in the study told researchers that they liked the product, found it easy to use, and preferred it to possible alternatives such as tablets or vaginal gels.

alt

Read more:

AIDS 2016: Study Looks at Use of HIV PrEP Before and During Pregnancy and Breastfeeding

Truvada for pre-exposure prophylaxis (PrEP) when it was offered as an additional tool for preventing HIV infection during the pre-conception period, pregnancy, and breastfeeding, according to study findings presented at the 21st International AIDS Conference (AIDS 2016) last month in Durban and published in the July 19 online edition of the American Journal of Obstetrics and Gynecology.

alt

Read more:

AIDS 2016: Realism Needed About the Benefits and Risks of Taking Part in HIV Cure Research

A significant proportion of people living with HIV would be willing to take part in a study towards a cure for HIV, according to research presented at the recent 21st International AIDS Conference (AIDS 2016) in Durban. However, some potential participants may not fully understand that taking part in an early-phase study is highly unlikely to afford any personal clinical benefit, but might have the potential to cause harm.

alt

Read more:

Truvada PrEP for HIV Prevention Approved in European Union

The European Commission, which has authority over new drug in the European Union, has approved Truvada (tenofovir/emtricitabine) for HIV pre-exposure prophylaxis or PrEP, Gilead Sciences announced this week. While this marketing authorization allows Truvada for PrEP to be sold throughout the EU, regulatory authorities in each country have the final say over whether to approve it and national health systems will decide whether to offer PrEP widely and pay for it.

alt

Read more:

AIDS 2016: HIV Will Only Be Cured with Combined Approaches, Conference Delegates Hear

Curing people of HIV infection will have to involve combinations of drugs and approaches, just as HIV treatment does, delegates heard at the Towards an HIV Cure workshop held in advance of the recent 21st International AIDS Conference (AIDS 2016) in Durban. The reason is the same, too: HIV can easily develop resistance to single agents, even ones as sophisticated as broadly neutralizing antibodies and gene-editing enzymes.

alt

Read more:

AIDS 2016: New HIV Infections Have Stopped Declining Worldwide, Now Rising in Some Regions

After a decade of rapidly declining HIV incidence following the introduction of effective antiretroviral treatment, progress in reducing new infections has stalled worldwide and in some areas incidence has started to increase, according to a new analysis from the Global Burden of Disease Study presented at the 21st International AIDS Conference (AIDS 2016) last month in Durban and published in the August 2016 edition of The Lancet HIV.

alt

Read more: